BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17234734)

  • 1. Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.
    Vallat LD; Park Y; Li C; Gribben JG
    Blood; 2007 May; 109(9):3989-97. PubMed ID: 17234734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
    Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
    Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
    Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
    Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
    Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
    Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
    Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
    J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
    von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
    Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
    Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
    Front Immunol; 2019; 10():2455. PubMed ID: 31681329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
    Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
    Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
    Mansouri L; Sutton LA; Ljungström V; Bondza S; Arngården L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sörqvist E; Lönn P; Muggen AF; Yan XJ; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellström M; Jernberg-Wiklund H; Ghia P; Söderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
    J Exp Med; 2015 Jun; 212(6):833-43. PubMed ID: 25987724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen.
    Kashuba E; Eagle GL; Bailey J; Evans P; Welham KJ; Allsup D; Cawkwell L
    J Proteomics; 2013 Oct; 91():478-85. PubMed ID: 23938224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
    Kienle D; Benner A; Kröber A; Winkler D; Mertens D; Bühler A; Seiler T; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2006 Mar; 107(5):2090-3. PubMed ID: 16322480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low
    Cavallini C; Chignola R; Dando I; Perbellini O; Mimiola E; Lovato O; Laudanna C; Pizzolo G; Donadelli M; Scupoli MT
    Blood; 2018 Apr; 131(17):1942-1954. PubMed ID: 29467184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia.
    Schleiss C; Carapito R; Fornecker LM; Muller L; Paul N; Tahar O; Pichot A; Tavian M; Nicolae A; Miguet L; Mauvieux L; Herbrecht R; Cianferani S; Freund JN; Carapito C; Maumy-Bertrand M; Bahram S; Bertrand F; Vallat L
    Leukemia; 2021 May; 35(5):1463-1474. PubMed ID: 33833385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.